Stefan Borov, Benito Baldauf, Jana Henke, Herribert Pavacci, Arben Perani, Bernhard Zrenner, Josef Dietl, Julinda Mehilli, Ernest W Lau, Reinhard Vonthein, Hendrik Bonnemeier
AIMS: TauroPace (TauroPharm, Bravaria Germany), a taurolidine solution for combating cardiac implantable electronic device (CIED) infection, was compared to a historical control of 3% hydrogen peroxide (H2O2) in a prospective observational study. METHODS: The device pocket was irrigated and all hardware accessible within (leads, suture sleeves, pulse generator) was wiped with H2O2, TauroPace or taurolidine in a galenic formulation during any invasive CIED procedures at the authors' institute...
October 13, 2023: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology